About this trial
WAYFIND-R is a global registry that will collect data from patients who have been diagnosed with a solid tumour and whose tumour has been profiled with a next-generation sequencing (NGS) test.
Patient Profile
For patients who have been diagnosed with a solid tumour and whose tumour has been profiled with a next-generation sequencing (NGS) test.
Where’s this trial being run?
St James’s Hospital, Tallaght University Hospital, and St Vincents University Hospital
Can I join this study / trial?
The first step we recommend is to talk to your doctor or the cancer trials team at your hospital. You can find contact details for cancer trials research units in Ireland here.
It’s also a good idea to print this page and bring it with you to your appointment. It can help guide the conversation and remind you of what to ask. You may also want to talk to your family or friends about your options, as they can offer support as you make decisions.
For more detailed information
Click HereQuestions?
Here’s a list of questions you may have for your doctor or local cancer research team.
QuestionsSummary Data
| Name: | WAYFIND-R |
|---|---|
| Number: | 21-30 |
| Full Title: | WAYFIND-R:A global registry collecting RWD (real world data) |
| Principal Investigator: | Prof. Ray McDermott |
|---|---|
| Type: | Industry Sponsored |
| Sponsor: | ROCHE |
| Recruitment Started: |
Global: Ireland: |
| Global Recruitment Target: | >15,000 patients in approx. 10 countries |
|---|---|
| Ireland Recruitment Target: | 300 |